Psoriasis Treatment: Traditional Therapy M Lebwohl, P T Ting, J Y M Koo
Total Page：16
File Type：pdf, Size：1020Kb
ii83 Ann Rheum Dis: first published as 10.1136/ard.2004.030791 on 11 February 2005. Downloaded from REPORT Psoriasis treatment: traditional therapy M Lebwohl, P T Ting, J Y M Koo ............................................................................................................................... Ann Rheum Dis 2005;64(Suppl II):ii83–ii86. doi: 10.1136/ard.2004.030791 they are occluded or if superpotent corticosteroids are used Even before the recent development of biological agents, a continuously over large areas of the body. However, the long list of effective treatments has been available for patients cutaneous side effects are more commonly problematic than with psoriasis. Topical therapies such as corticosteroids, significant HPA axis suppression, which is seldom an issue.8 vitamin D analogues, and retinoids are used for localised One of the most troubling features of topical corticosteroids disease. Phototherapy including broadband ultraviolet B is that patients develop tachyphylaxis, a phenomenon (UVB), narrowband UVB, PUVA, and climatotherapy are whereby medications that are highly effective initially, lose effective for more extensive disease. Systemic therapies such efficacy with prolonged use. To avoid tachyphylaxis and the as methotrexate, retinoids, and ciclosporin are effective for other side effects of topical corticosteroids, regimens have patients with refractory or extensive cutaneous disease. been developed in which superpotent corticosteroids are applied twice daily for two weeks, after which they are applied on weekends only. Strong topical corticosteroids should also be avoided on the face and intertriginous sites, ven prior to the development of biologicals, the treat- areas that are more prone to steroid side effects. The quantity ment of psoriasis was quite comprehensive, including of strong topical corticosteroids applied should be limited to numerous topical, systemic, and light therapies 50 or 60 g per week, and occlusion should be avoided except E 12 (table 1). Most of these continue to play a role in modern on the scalp, palms, and soles. Strong corticosteroids should psoriasis therapy. be avoided or used cautiously in children. The second most commonly used group of medications TOPICAL THERAPY consists of the vitamin D analogues. In the USA, calcipotriene Most patients with psoriasis have skin lesions limited to is available in ointment, cream, and solution formulations. localised areas such as the elbows or knees. For these This agent is applied twice daily and is most often used in patients, topical therapy may remain part of their therapeutic conjunction with topical corticosteroids. Its commonest side regimen whether or not they require additional treatments effect is irritation, primarily on the face and intertriginous for psoriatic arthritis. Even those treated with phototherapy sites. If large quantities of calcipotriene are applied, absorp- or systemic therapies, including biologicals, have residual tion of this vitamin D analogue can result in hypercalcaemia.9 lesions that may require topical remedies. Consequently, less than 120 g should be used weekly. Topical Topical corticosteroids remain the most widely prescribed calcitriol is available in other parts of the world and may be http://ard.bmj.com/ medications for plaque psoriasis. These range in strength less irritating on the face and in intertriginous sites. Other from weak, over-the-counter steroids such as 1% hydro- vitamin D analogues such as tacalcitol are also being used for cortisone to superpotent corticosteroids, such as clobetasol psoriasis. Some vitamin D analogues are unstable, and propionate, halobetasol propionate, betamethasone dipropio- nate in optimised base, and diflorasone diacetate in Table 1 Psoriasis treatments before biologicals augmented base (table 2). The Stoughton–Cornell classifica- tion ranks the potency of topical corticosteroids on their Topical therapy Phototherapy ability to induce vasoconstriction.3 Topical corticosteroids are on September 26, 2021 by guest. Protected copyright. available in numerous vehicles including powders, sprays, Anthralin UVB Calcipotriene Narrowband UVB lotions, solutions, creams, emollient creams, ointments, gels, Calcitriol PUVA and tape. Recently, clobetasol propionate and betamethasone Corticosteroids Bath-PUVA valerate have both been introduced in foam vehicles that are Salicylic acid Climatotherapy cosmetically elegant and should improve compliance. Tars Excimer laser Tazarotene Different vehicles are used on different body sites. For example, the scalp and other hair bearing areas are most Systemic therapy Unconventional therapy easily treated with foams, solutions, and gels. Creams are Methotrexate Antibiotics most useful for daytime use, and ointments, which are often Retinoids Azathioprine more effective but less appealing cosmetically, can be applied Ciclosporin Oral calcitriol at night. Two possible exceptions are the newer foam Colchicine FK-506 vehicles, which have comparable clinical efficacy to oint- Topical 5-fluorouracil 45 ments. Fumaric acid esters Side effects of topical corticosteroids, especially those that Hydroxyurea carry the superpotent categorisation, include cutaneous Mycophenolate mofetil Propylthiouracil atrophy, development of striae, formation of telangiectasia, Sulfasalazine and a host of other local cutaneous effects such as the 6-Thioguanine formation of an acneiform eruption known as perioral Cryotherapy dermatitis on the face.67 Hypothalamic–pituitary–adrenal Radiation therapy (HPA) axis suppression can occur with prolonged use of excessive quantities of topical corticosteroids, particularly if www.annrheumdis.com ii84 Lebwohl, Ting, Koo Ann Rheum Dis: first published as 10.1136/ard.2004.030791 on 11 February 2005. Downloaded from phototherapy.16 In the few years that narrowband UVB Table 2 Classifications of commonly prescribed phototherapy has been used, no increase in cutaneous corticosteroids malignancies has been reported. More experience will be Relative potency Generic (brand) name needed to firmly establish the safety of narrowband UVB phototherapy. The excimer laser is a powerful beam of Super high potency Clobetasol dipropionate 0.05% (Temovate) (Olux foam) 308 nm light (another form of narrowband ultraviolet light) Betamethasone dipropionate 0.05% (Diprolene) that has been used successfully to treat localised plaques of Halobetasol propionate 0.05% (Ultravate) psoriasis including those on the palms and soles.18 Diflorasone diacetate 0.05% (Psorcon) In the 1970s, a powerful new treatment of psoriasis known High potency Fluocinonide 0.05% (Lidex) as PUVA was introduced. PUVA involves the ingestion or Halcinonide 0.05% (Halog) topical application of a photosensitising medication, usually Amcinonide 0.05–0.1% (Cyclocort) 8-methoxypsoralen. Patients are then exposed to UVA, which Desoximetasone 0.25% (Topicort) activates the 8-methoxypsoralen. Once activated, this drug Mid potency Hydrocortisone valerate 0.2% (Westcort) crosslinks DNA strands preventing replication of keratino- 19 Triamcinolone acetonide 0.1% (Kenalog) cytes and induces death of activated T cells in skin. Bath Betamethasone valerate 0.1% (Valisone) PUVA, a topical photosensitising method, involves immersion (Luxiq foam) of either localised areas (such as the hands or feet) or the Flurandrenolide 0.05% (Cordran) whole body in water containing dissolved 8-methoxypsoralen Mometasone furoate 0.1% (Elocon) capsules prior to UVA exposure. The topical use of this agent Low potency Hydrocortisone 0.5–2.5% (,1% OTC; is not associated with adverse systemic symptoms such as .1% prescription) nausea. Psoriasis clears in most patients treated with PUVA. Desonide 0.05% lotion, cream, ointment PUVA may also benefit psoriatic arthritis in some patients.20 (Desocort) Dexamethasone 0.1% (Decadron) For optimal effect, patients are typically treated two to three times per week for several months. PUVA is significantly OTC, over the counter. more effective than broadband UVB, but it is associated with the development of squamous cell carcinomas of the skin. The risk of non-melanoma cutaneous malignancies increases with the number of treatments but are rare in dark skinned consequently, they should only be combined with other patients.21 Most recently, there have been unconfirmed medications that have been demonstrated not to affect their reports of an increased risk of malignant melanomas that 10 stability. Phototherapy may inactivate vitamin D analogues correlates with the number of treatments and time of follow and, conversely, vitamin D analogues may block the up, the increased risk being noted 15 years after starting therapeutic component of ultraviolet light; thus these topical PUVA.22 11 agents should be applied after phototherapy, not before. Climatotherapy, the oldest form of phototherapy involving Tazarotene gel, a recently developed topical retinoid for exposure to sunlight, is well established at a number of psoriasis, is available in 0.05% and 0.1% gels and creams. clinics around the world. Perhaps the most successful is the Topical retinoids may reverse some of the cutaneous atrophy psoriasis treatment centre at the Dead Sea.23 At 300 m below 12 caused by topical corticosteroids but are associated with sea level, the Dead Sea is the lowest point on earth. Its local cutaneous irritation. Thus, they are often prescribed in mineral content is greater than that of any other naturally combination with topical corticosteroids.13 occurring body of water on earth.